Confirmation of self-report of HIV testing among a cohort of pregnant women

Journal of Clinical Epidemiology

Volumn 50, Issue 1, 1997, Pages 57-61

  O'Campo, Patricia ^a,b   De Boer, Melanie ^a   Faden, Ruth ^a   Kass, Nancy ^a   Gielen, Andrea ^a   Barbacci, Marguerite ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NONE

Author keywords

AIDS; HIV; Pregnancy

Indexed keywords

ANTIVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DATA BASE; FEMALE; HOSPITAL LABORATORY; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; SCREENING TEST; SELF REPORT; VERTICAL TRANSMISSION;

BALTIMORE; CLINICAL APPROACH/SOURCE; EMPIRICAL APPROACH; GENETICS AND REPRODUCTION; HEALTH CARE AND PUBLIC HEALTH; PREGNANT WOMEN; SURVEY;

ADULT; COHORT STUDIES; DISCLOSURE; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; PATIENT PARTICIPATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN;

EID: 0031046324     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(96)00301-0     Document Type: Article

References (15)

1. 1. National Center for Health Statistics. Annual Summary of Births, Marriages, Divorces, and Deaths: U.S., 1993 (monthly vital statistics report, Vol. 42, No. 13). Hyattsville, Maryland: U.S. Public Health Service; 1994.
2. 2. CDC National HIV Seroprevalence Summary: Results Through 1992. Vol 3. Atlanta, Georgia: U.S. Department of Health and Human Services; 1994.
3. 3. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-1180.
4. 4. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. Morb Mortal Wkly Rep 1987; 36: 509-515.
5. 5. United States Public Health Service Recommendations for HIV Counseling and Testing for Pregnant Women. Atlanta, Georgia: Centers for Disease Control and Prevention; 1995.
6. 6. Characteristics of, and HIV infection among, women served by publicly funded HIV counseling and testing services -United States, 1989-1990. JAMA 1991; 24: 265: 2051-2052.
7. 7. Wilson J. Human Immunodeficiency Virus Antibody Testing in Women 15-44 Years of Age: United States 1990 (U.S. DHHS Advance Data No. 238). Washington, DC: U.S. Government Printing Office; 1993.
8. 8. O'Campo P, de Boer MA, Faden RR, et al. Discrepancies between women's personal interview data and medical record documentation of illicit drug use, sexually transmitted diseases and HIV infections. Med Care 1992; 30: 965-971.
9. 9. Faden R, Chaisson R, Gielen A, et al. Prenatal HIV antibody testing and the meaning of consent. AIDS Public Policy 1994; 9: 151-159.
10. 10. Kass N, Faden R, Gielen A, et al. Pregnant women's knowledge of HIV: Implications for education and counseling. Women's Health Issues 1992; 2: 17-25.
11. 11. Fleiss J. Statistical Methods for Rates and Proportions. 2nd ed. New York: Wiley; 1981.
12. 12. McCusker J, Stoddard AM, McCarthy E. The validity of self-reported HIV antibody test results. Am J Public Health 1992; 82: 567-569.
13. 13. Craven DE, Steger KA, La Chapelle R, Allen DM. Factitious HIV infection: The importance of documenting infection. Ann Intern Med. 1994; 121: 763-766.
14. 14. Shoen AR, Fox HE, Alexander G, Buck A, Higgins A, McDermott SM, Moroso G, Moye J, Pacheco-Acosta E. Misdiagnosed HIV infection in pregnant women: Implications for clinical care. Public Health Reports 1994; 109: 694-699.
15. 15. Harrow A. Undocumented HIV infection. Ann Intern Med. 1995; 123: 470.